2,851
edits
Line 71: | Line 71: | ||
=== Metabolism=== | === Metabolism=== | ||
A study with <sup>14</sup>C-labeled CoQ<sub>10</sub> in rats showed most of the radioactivity in the liver two hours after oral administration when the peak plasma radioactivity was observed, but CoQ<sub>9</sub> (with only 9 isoprenyl units) is the predominant form of coenzyme Q in rats.<ref>{{cite book |first1=H. |last1=Kishi |first2=N. |last2=Kanamori |first3=S. |last3=Nisii |first4=E. |last4=Hiraoka |first5=T. |last5=Okamoto |first6=T. |last6=Kishi |chapter=Metabolism and Exogenous Coenzyme Q<sub>10</sub> in vivo and Bioavailability of Coenzyme Q<sub>10</sub> Preparations in Japan |title=Biomedical and Clinical Aspects of Coenzyme Q |pages=131–142 |publisher=Elsevier |location=Amsterdam |year=1964}}</ref> It appears that CoQ<sub>10</sub> is metabolised in all tissues, while a major route for its elimination is biliary and fecal excretion. After the withdrawal of CoQ<sub>10</sub> supplementation, the levels return to normal within a few days, irrespective of the type of formulation used.{{pmid|3718593}} | |||
===Pharmacokinetics=== | ===Pharmacokinetics=== |